Targeting the myocardial sodium–hydrogen exchange for treatment of heart failure

Author：

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.3, 2002-06, pp. : 291-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of sodium-hydrogen exchange as therapeutic agents for the treatment of heart disease

By Karmazyn Morris

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. : 1411-1425

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction

Heart Drug, Vol. 1, Iss. 2, 2004-11 ,pp. : 71-76

Karger

Access to resources Recommend Favorite

Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure

Current Drug Targets, Vol. 16, Iss. 14, 2015-12 ,pp. : 1682-16

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of Na-H exchange inhibitors for the treatment of heart failure

By Karmazyn M.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 835-843

Informa Healthcare

Access to resources Recommend Favorite

Contribution of sodium channel and sodium/hydrogen exchanger to sodium accumulation in the ischemic myocardium

By Tanonaka K. Takasaki A. Kajiwara H. Takeo S.

General Pharmacology, Vol. 34, Iss. 3, 2000-03 ,pp. : 167-174

Elsevier

Access to resources Recommend Favorite